- Home
- RCKT vs WEYS Comparison
RCKT vs WEYS Comparison
Compare RCKT & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- WEYS
- Stock Information
- Founded
- RCKT 1999
- WEYS 1906
- Country
- RCKT United States
- WEYS United States
- Employees
- RCKT N/A
- WEYS 580
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- WEYS Apparel
- Sector
- RCKT Health Care
- WEYS Consumer Staples
- Exchange
- RCKT Nasdaq
- WEYS Nasdaq
- Market Cap
- RCKT 328.6M
- WEYS 294.5M
- IPO Year
- RCKT N/A
- WEYS N/A
- Fundamental
- Price
- RCKT $3.28
- WEYS $30.87
- Analyst Decision
- RCKT Buy
- WEYS
- Analyst Count
- RCKT 13
- WEYS 0
- Target Price
- RCKT $12.96
- WEYS N/A
- AVG Volume (30 Days)
- RCKT 5.9M
- WEYS 14.3K
- Earning Date
- RCKT 11-06-2025
- WEYS 11-04-2025
- Dividend Yield
- RCKT N/A
- WEYS 3.50%
- EPS Growth
- RCKT N/A
- WEYS N/A
- EPS
- RCKT N/A
- WEYS 2.69
- Revenue
- RCKT N/A
- WEYS $281,051,000.00
- Revenue This Year
- RCKT N/A
- WEYS N/A
- Revenue Next Year
- RCKT $108.43
- WEYS N/A
- P/E Ratio
- RCKT N/A
- WEYS $11.48
- Revenue Growth
- RCKT N/A
- WEYS N/A
- 52 Week Low
- RCKT $2.19
- WEYS $25.51
- 52 Week High
- RCKT $22.01
- WEYS $41.05
- Technical
- Relative Strength Index (RSI)
- RCKT 51.09
- WEYS 52.73
- Support Level
- RCKT $3.16
- WEYS $29.91
- Resistance Level
- RCKT $3.40
- WEYS $31.50
- Average True Range (ATR)
- RCKT 0.27
- WEYS 0.87
- MACD
- RCKT -0.01
- WEYS 0.18
- Stochastic Oscillator
- RCKT 32.79
- WEYS 82.83
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About WEYS Weyco Group Inc.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.